-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FO1xUcME2K5c0NuJOgEu3e9/TtJFRHZxe7O2mtN1H9IiH483CuyqapuiblVK8rTZ xV3FVtKSx3/qgJ4BxAtwzw== 0001104659-05-044705.txt : 20050919 0001104659-05-044705.hdr.sgml : 20050919 20050919164254 ACCESSION NUMBER: 0001104659-05-044705 CONFORMED SUBMISSION TYPE: 8-A12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050919 DATE AS OF CHANGE: 20050919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 FILING VALUES: FORM TYPE: 8-A12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 051091678 BUSINESS ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 8-A12G 1 a05-16413_18a12g.htm 8-A12G

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Sunesis Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

 

94-3295878

(State of Incorporation

 

(I.R.S. Employer

or Organization)

 

Identification No.)

 

 

 

341 Oyster Point Boulevard, South San Francisco, California

 

94080

(Address of Principal Executive Offices)

 

(Zip Code)

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A. (c), please check the following box.  o

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.  ý

 

Securities Act registration statement file number to which this form relates:  333-121646

 

Securities to be registered pursuant to Section 12(b) of the Act:   None.

 

Securities to be registered pursuant to Section 12(g) of the Act:

 

Common Stock, par value $0.0001

(Title of Class)

 

 


 

Item 1.

 

Description of Registrant’s Securities to be Registered.

 

The description of the Common Stock of Registrant set forth under the caption “Description of Capital Stock” in Registrant’s Registration Statement on Form S-1 (File No. 333-121646) as originally filed with the Securities and Exchange Commission on December 23, 2004, as amended (the “Registration Statement”), and in the prospectus included in the Registration Statement, is hereby incorporated by reference in response to this item.

 

Item 2.

 

The following exhibits are filed herewith or are incorporated by reference as indicated below.

 

Exhibit Number

 

Description

 

 

 

 

 

3.3*

 

Amended and Restated Certificate of Incorporation of the Registrant (Delaware) to be effective prior to the closing of the offering.

 

 

 

 

 

3.5*

 

Amended and Restated Bylaws of the Registrant to be effective upon the closing of the offering.

 

 

 

 

 

4.1*

 

Specimen Common Stock certificate of the Registrant.

 

 

 

 

 

10.17*

 

Eighth Amended and Restated Investor Rights Agreement, dated August 30, 2004, by and among the Registrant and certain stockholders and warrant holders.

 

 

 

 

 

10.39**

 

Amendment to Eighth Amended and Restated Investor Rights Agreement, dated April 27, 2005, by and among the Registrant and Investors listed on the signature pages thereto.

 

 

 

 

 

10.40***

 

Amendment to Eighth Amended and Restated Investor Rights Agreement, dated August 25, 2005, by and among the Registrant and Investors listed on the signature pages thereto.

 

 

* Incorporated by reference to the identically numbered exhibit to the Registration Statement on Form S-1 of Sunesis Pharmaceuticals, Inc. filed by Sunesis Pharmaceuticals, Inc. on December 23, 2004 (File No. 333-121646).

 

** Incorporated by reference to the identically numbered exhibit to Amendment No. 2 to the Registration Statement on Form S-1 of Sunesis Pharmaceuticals, Inc. filed by Sunesis Pharmaceuticals, Inc. on April 29, 2005 (File No. 333-121646).

 

*** Incorporated by reference to Exhibit 10.39 to Amendment No. 4 to the Registration Statement on Form S-1 of Sunesis Pharmaceuticals, Inc. filed by Sunesis Pharmaceuticals, Inc. on September 1, 2005 (File No. 333-121646).

 

2


 

SIGNATURE

 

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date:    September 19, 2005

Sunesis Pharmaceuticals, Inc.

 

 

 

 

 

 

 

By:

/s/ Daryl B. Winter, Ph.D.

 

 

 

Daryl B. Winter, Ph.D.

 

 

Senior Vice President, General Counsel and
Corporate Secretary

 

3

 -----END PRIVACY-ENHANCED MESSAGE-----